Fuji Oil Co., Ltd. Lifts FY2027 Guidance on Chocolate Unit Turnaround

Fuji Oil Co., Ltd. (TSE:2607), a global leader in commercial chocolate and plant-based oils, reported a dramatic recovery in profitability for the fiscal year ended March 2026, with operating profit surging 171.8% year-over-year despite modest revenue growth. The company’s core chocolate business swung from a significant loss to profitability, signaling successful execution of its medium-term restructuring strategy. Management projects continued margin expansion in FY2027, though it expects a modest revenue contraction amid uncertain global trade conditions.

Key Financial Results (FY2026, ended March 2026)

Business Overview

Fuji Oil Co., Ltd. is a diversified oils and fats manufacturer with dominant positions in commercial chocolate for confectionery applications and plant-based protein ingredients. The company operates three primary segments: plant-based oils, commercial chocolate, and soy-based food materials. Its chocolate products are used globally by major confectionery manufacturers, while its plant-based oils serve food processors and industrial customers across Asia, Europe, and North America.

Analysis: Profitability Recovery Outpaces Revenue Growth

The headline story is the non-linear relationship between revenue and profit expansion. While revenue grew a respectable 15.1% to JPY 772.3bn, operating profit more than doubled, climbing JPY 22.8bn to JPY 36.0bn. This disproportionate profit growth reflects a fundamental shift in business mix and operational efficiency rather than simple top-line leverage.

The commercial chocolate segment—which accounts for 48% of revenue at JPY 370.9bn—was the primary driver. This division reversed a prior-year loss of JPY 16.2bn to generate JPY 16.6bn in profit, a swing of JPY 32.8bn. This turnaround is material: it represents the successful resolution of what appeared to be a structural profitability problem in the company’s largest business unit. The segment’s 10.8% revenue growth coupled with this dramatic profit recovery suggests that pricing actions, product mix optimization, and cost discipline are all contributing.

The plant-based oils segment delivered even stronger momentum, with revenue up 30.7% and segment profit up 24.7%, indicating that volume growth is outpacing margin expansion in this division—a healthy sign of market share gains rather than pure price increases.

However, the soy-based food materials segment deteriorated, with revenue declining 5.9% and segment profit falling 57%. This weakness suggests structural headwinds in plant-based protein markets or competitive pressure that management has not yet addressed.

Operating margin improved to 4.7% from 2.0% in the prior year, though this remains below typical industry benchmarks. The company’s ordinary income (keijo rieki, Japan’s recurring profit metric that includes non-operating items) surged 239.5% to JPY 23.4bn, a gain that outpaced operating profit growth. This divergence reflects a favorable swing in non-operating items, particularly a reduction in losses from equity-method investments, which fell from JPY 1.7bn to JPY 239M. International investors should note that ordinary income is a Japan-specific metric distinct from operating profit and can fluctuate significantly based on financial income and investment-related gains or losses.

Net profit doubled to JPY 11.5bn, reflecting both the operating profit recovery and improved non-operating performance. Cash flow from operations rebounded sharply to JPY 54.8bn from a negative JPY 48.8bn in the prior year, confirming that the profit recovery is translating into actual cash generation rather than accounting artifacts.

Next Year Guidance

Management’s FY2027 guidance reflects a cautious stance on near-term demand while signaling confidence in margin expansion. Revenue is projected to decline 2.4% to JPY 754.0bn, suggesting management expects headwinds from U.S. tariff policy and uncertain China demand. Operating profit is forecast to grow a modest 4.0% to JPY 37.5bn, implying slight margin compression despite the revenue decline—a conservative assumption that may provide upside if cost initiatives accelerate. Net profit is projected to surge 75.0% to JPY 19.5bn, driven by anticipated improvements in non-operating items and tax efficiency. The sharp divergence between operating profit growth (+4.0%) and net profit growth (+75.0%) warrants close monitoring of non-operating line items in coming quarters.

What to Watch

Chocolate segment sustainability: The JPY 32.8bn profit swing in commercial chocolate is the linchpin of the turnaround. Investors should monitor whether this improvement reflects durable structural change or temporary factors such as one-time cost reductions or favorable product mix that may not persist.

Soy protein stabilization: The 57% profit decline in the soy-based materials segment is a red flag. Management must articulate a credible strategy to arrest this deterioration, whether through pricing, cost reduction, or portfolio rationalization.

Non-operating volatility: The 239.5% surge in ordinary income was driven largely by non-operating items. Clarification of the sustainability of these gains—particularly the reduction in equity-method investment losses—is essential for assessing normalized earning power.

Source: Original filing (TDnet) | 日本語版

This article is for informational purposes only and does not constitute investment advice. Financial figures are AI-extracted and may contain errors — always verify against the original filing.